[1] |
CHEN Kun, YANG Hui, LIU Zijia, ZHANG Xiaolin, XU Zhuoyi, LIU Bing, ZHAO Yubao, DING Lu, DENG Yang.
Expression of HLA-DRA protein in hepatocellular carcinoma and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 84-89.
|
[2] |
HUANG Chuntao, WEN Tianbin, LYU Sihui, LIANG Jinlan, WANG Qi.
Construction and validation of a prognostic model for cervical cancer based on tumor immune cycle-related genes
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(4): 398-405.
|
[3] |
CHEN Xiaoqi, ZHAO Bingbing, LI Zhuang, FENG Yanying, YANG Zhijun.
The role and mechanism of piR-hsa-130912 in promoting proliferation,invasion and migration ofepithelial ovarian cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 263-271.
|
[4] |
WANG Feiqian, NUMATA Kazushi, RUAN Litao, NAKANO Masayuki, BAI Xiaoxu, LIU Yuxin, QU Kai.
Contrast enhanced ultrasound combined with immunohistochemistry in the diagnosis of microvascular invasion of small hepatocellular carcinoma: a retrospective study in two hospitals
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(5): 534-540.
|
[5] |
YUAN Jianhua, ZHANG Shubo, LI Jianwang, MAO Shanshan, CUI Ronghua, ZHANG Gang.
Expression and correlation of GPRC5A,SOCS3
and STAT3 in colorectal cancer tissues
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(6): 518-522.
|
[6] |
QIU Liyu, LI Ni, WU Guili.
Quality of life in advanced ovarian cancer patients undergoing hyperthermic intraperitoneal chemotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(5): 430-433.
|
[7] |
KE Qing, DUAN Ying, HUANG Wenqiang, TAN Xiaohong, CEN Hong.
Expression of MYC in diffuse large B-cell lymphoma and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(4): 289-296.
|
[8] |
XU Dongyun, WANG Juan, LI Ke, YU Guanzhen, YU Wenlong, XU Yongmao.
Expression of HOXC8 in hilar cholangiocarcinoma and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(2): 116-120.
|
[9] |
Zhan Yongjie,Wu Tengfei,Mao Naiquan.
Correlation between HPV 16/18 infection and p53 expression in esophageal squamous cell carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(6): 444-448.
|
[10] |
Tang Yuqi,Yu Hongjing,Shi Lijun,ZouYupeng,Feng Yan,Wang Qi.
Analysis of poor prognosis leaded by CCL18 mediated chemokine network in tumor microenvironment in ovarian cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(5): 345-351.
|
[11] |
Lu Meiyan,Huang Zaiming,Yang Zhijun.
Prediction and identification of HLA-A2-restricted CTL epitopes from ovarian cancer-associated antigen TM4SF1
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(3): 198-204.
|
[12] |
Yi Xuemei,Xue Li,Zhang Jing,Qiao Yujie,Jin Qianqian,Li Hongling.
Expression of nuclear factor erythroid-2-related factor 2 in peripheral T-cell lymphoma and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(3): 209-212.
|
[13] |
Li Haimei, Yu Jinxia, Yang Haijun.
Clinical pathological analysis of 10 cases of ovarian sclerosingstromal tumor
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(2): 132-136.
|
[14] |
Han Yanyan,Zhu Junbao,Li Shuhua.
Clinical significance of Caveolin-1 expression in endometrial carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(3): 201-204.
|
[15] |
Liang Xiaoqin,Wang Zhuo|,Chang Shoufeng,Zhang Xiaoling,Chen Cheng,Wang Jinsui,Su Qinjun.
ROS1 expression in pulmonary adenocarcinoma and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(6): 364-368.
|